Cargando…

CD8(+) Regulatory T Cell Deficiency in Elderly-Onset Rheumatoid Arthritis

Elderly-onset rheumatoid arthritis (EORA) is associated with higher disease activity and accelerated joint destruction compared with young-onset RA (YORA). However, the underlying immunological mechanism remains unclear. Regulatory T cells (Tregs) are an immunosuppressive T cell subset, and CD4(+) T...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Ryu, Kadoba, Keiichiro, Tamamoto, Atsuko, Murata, Koichi, Murakami, Kosaku, Onizawa, Hideo, Fujii, Takayuki, Onishi, Akira, Tanaka, Masao, Ito, Hiromu, Morinobu, Akio, Hashimoto, Motomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054757/
https://www.ncbi.nlm.nih.gov/pubmed/36983342
http://dx.doi.org/10.3390/jcm12062342
Descripción
Sumario:Elderly-onset rheumatoid arthritis (EORA) is associated with higher disease activity and accelerated joint destruction compared with young-onset RA (YORA). However, the underlying immunological mechanism remains unclear. Regulatory T cells (Tregs) are an immunosuppressive T cell subset, and CD4(+) Tregs are deficient and/or dysfunctional in RA; however, CD8(+) Tregs have not been fully examined in RA. Here, we aimed to determine the role of CD8(+) Tregs, particularly in EORA. A total of 40 patients (EORA, n = 17; YORA, n = 23) were cross-sectionally enrolled. Current disease activity and treatment were comparable between the two groups; however, levels of multiple cytokines, including IL-1β, TNFα, interferon (IFN)-γ, IL-2, and IL-10, were significantly increased in EORA. The number of CD4(+) Tregs did not differ between the groups (p = 0.37), but those of CD8(+) Tregs were significantly decreased in EORA (p = 0.0033). The number of CD8(+) Tregs were inversely correlated with plasma matrix metalloprotease (MMP)-3 levels (r = −0.3331, p = 0.036). Our study results revealed an intrinsic deficiency of CD8(+) Tregs in patients with EORA, which leaves synovitis unchecked with excessive MMP-3 release. A therapeutic approach to restore CD8(+) Tregs may provide a new avenue for the treatment of EORA.